Study S000216

Changes of Gut Microbiome Following Liraglutide Treatment in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: A Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, 28-week Trial

ClinicalTrials.gov record

Registration

Registration: NCT04525300
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: UNKNOWN
Enrollment: 300
Start: 2020-05-24
Primary completion: 2022-06
Lead sponsor: Xiangya Hospital of Central South University
Conditions: Obesity
Interventions: DRUG:Liraglutide; DRUG:placebo
Results posted: FALSE

Registered primary outcomes

The composition of the gut microbiota from baseline to end of treatment. [week 28]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.